Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Syri Limited, Unit 4, Bradfield Road, Ruislip, Middlesex, HA4 0NU, UK Trading as: Thame Laboratories, Unit 4, Bradfield Road, Ruislip, Middlesex, HA4 0NU, UK OR Trading as: SyriMed, Unit 4, Bradfield Road, ...
Syrisal 1 mmol/ml Oral Solution.
| Pharmaceutical Form |
|---|
|
Oral solution. A clear, colourless solution. |
Each ml of oral solution contains 1 mmol (58.44 mg) of sodium chloride.
Excipients with known effect: Each ml of oral solution contains 0.8 mg of methyl parahydroxybenzoate (E218), 0.05 mg of propyl parahydroxybenzoate (E216), 0.05 ml (63 mg/ml) of glycerol (E422) and 23mg of sodium.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Sodium chloride |
Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue. |
| List of Excipients |
|---|
|
Glycerol (E422) |
Bottle: Amber or clear glass.
Closure: Child resistant plastic screw cap.
Pack size: 100ml and 300ml.
Not all pack size may be marketed.
Dosing Device: 20 ml dosage syringe with 1 ml graduation mark and a syringe adaptor.
Syri Limited, Unit 4, Bradfield Road, Ruislip, Middlesex, HA4 0NU, UK
Trading as:
Thame Laboratories, Unit 4, Bradfield Road, Ruislip, Middlesex, HA4 0NU, UK
OR
Trading as: SyriMed, Unit 4, Bradfield Road, Ruislip, Middlesex, HA4 0NU, UK
PL 39307/0001
Date of first Authorisation: 05 September 2016
Date of last renewal: 13 August 2021
| Drug | Countries | |
|---|---|---|
| SYRISAL | Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
